Biotech is back
FT News Briefing
00:00
Renewed Enthusiasm in U.S. Biotech Investment
This chapter explores the renewed investor interest in U.S. biotech shares, driven by the stabilization of interest rates and the successful development of COVID-19 vaccines. It also highlights key acquisitions and positive drug development news that are fueling a fresh wave of enthusiasm within the sector.
Transcript
Play full episode
